A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2011
11/16/2011	EP1746999B1 4-phenylamino-quinazolin-6-yl-amides
11/16/2011	EP1506166B1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/16/2011	EP1019439B1 Soluble single-chain t-cell receptor proteins
11/16/2011	CN1895421B Chinese animal medicine for improving fowl growth
11/16/2011	CN102245757A Stem cell for therapeutic use which is derived from human monocyte, and method for inducing same
11/16/2011	CN102245607A Morpholinopurine derivative
11/16/2011	CN102241673A Acrylamide compounds and medicinal uses thereof
11/16/2011	CN102240316A Method for extracting anthocyanin containing extract from cowberry
11/16/2011	CN102240315A Purification and application of anti-angiogenesis effective part of cowherb seed
11/16/2011	CN102240304A Formulation for breeding sea cucumbers, shrimps or abalones
11/16/2011	CN102240289A Pharmaceutical composition containing flibanserin polymorph a
11/16/2011	CN102240264A Application of poly(cinnamic alcohol) injection used as cyst treatment medicament
11/16/2011	CN101874881B Chinese medicinal composition and application thereof
11/16/2011	CN101647515B Chinese herbal growth promoter, preparation method and application thereof
11/16/2011	CN101395168B Galactose derivative,Drug carrier and medicinal composition
11/16/2011	CN101172980B Method for the preparation of hexahydro-furo 2,3-b furan-3-ol
11/16/2011	CN101137364B Compositions comprising an epothilone and production methods
11/16/2011	CN101128193B Anti-radical agents
11/15/2011	US8058445 Substituted pyridinecarboxamides for the treatment of cancer
11/15/2011	US8058441 For control fertility, contraception, breast cancer, prostate cancer and endometriosis; modulating activity of the follicle stimulating hormone (FSH) receptor; 1-Acetyl-6-(tert-butoxycarbonyl)amino-4-phenyl-1,2,3,4-tetrahydro-2,2,4-trimethylquinoline
11/15/2011	US8058425 Purine derivatives as kinase inhibitors
11/15/2011	US8058314 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
11/15/2011	US8058305 Pyrrolidine derivatives as prostaglandin modulators
11/15/2011	US8058301 Valsartan; hypotensive agents, cardiovascular disorders, anticholesterol agents, antilipemic agents
11/15/2011	US8058292 Therapeutic agents useful for treating pain
11/15/2011	US8058282 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy
11/15/2011	US8058280 Substituted thieno[2,3-d]pyrimidin-2,4-dione compounds and uses thereof
11/15/2011	US8058277 Substituted indoles
11/15/2011	US8058249 Immunostimulatory nucleic acid molecules
11/15/2011	US8058248 Foot and mouth disease virus vaccine comprising interferons
11/15/2011	US8058245 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
11/15/2011	US8058239 HMGB1 protein inhibitorsand/or antagonists for the treatment of vascular diseases
11/15/2011	US8058048 Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
11/15/2011	US8057814 Drug delivery from stents
11/15/2011	US8057801 Tick galectin
11/15/2011	US8057791 Human antibodies specific to KDR and uses thereof
11/15/2011	CA2624123C Glucagon-like peptide-1 secretagogue, glucagon-like peptide-1 secretagogue food or drink, inhibitor of postprandial rise in blood glucose, and inhibitory food or drink of postprandial rise in blood glucose
11/15/2011	CA2488611C Compounds for modulating the activity of exchange proteins directly activated by camp (epacs)
11/15/2011	CA2469612C Treatment of statin side effects using uridine derivatives
11/15/2011	CA2435067C Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
11/15/2011	CA2429979C Treatment of statin side effects
11/15/2011	CA2372655C Recombinant adenovirus having low pre-existing neutralizing activity
11/15/2011	CA2352537C Tgf.beta.1-inhibitor peptides
11/15/2011	CA2189349C Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
11/10/2011	WO2011138956A1 Novel prenylarene compound and use thereof
11/10/2011	WO2011138916A1 Polycyclic compound
11/10/2011	WO2011138842A1 Therapeutic agent for rheumatoid arthritis
11/10/2011	WO2011138142A1 Compositions and use of sulfasalazine
11/10/2011	WO2011137540A1 Gfi1b modulation and uses thereof
11/10/2011	US20110275810 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors
11/10/2011	US20110275706 Pharmaceutical Compositions Containing Lipase Inhibitors
11/10/2011	US20110275680 Noxel oxime derivatives of 3, 5-seco-4-nor-cholestane, pharmaceutical compositions containing same, and method for preparing same
11/10/2011	US20110275671 Dihydroindolinone derivatives
11/10/2011	US20110275669 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
11/10/2011	US20110275651 Fused ring heteroaryl kinase inhibitors
11/10/2011	US20110275641 Preventives or remedies for Alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
11/10/2011	US20110275640 Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
11/10/2011	US20110275632 Method for preventing or treating a disease related to the glucocorticoid receptor
11/10/2011	US20110275615 Novel substituted amides, their preparation and use
11/10/2011	US20110275573 Tissue adhesive
11/10/2011	US20110275555 Compositions containing delta-9-thc-amino acid esters and process of preparation
11/10/2011	US20110274764 Flavored colonic cleansing system
11/10/2011	US20110274739 Methods for governing tissue growth
11/10/2011	US20110274737 Implantable materials having engineered surfaces and method of making same
11/10/2011	US20110274715 Methods and compositions for cooling the human body
11/10/2011	US20110274703 Detection and treatment of non-dermal fibrosis
11/10/2011	US20110274696 Antibodies to ccr2
11/10/2011	US20110274679 Compositions and Methods of SIRT Activation
11/10/2011	US20110274674 Ischemic tissue cell therapy
11/10/2011	US20110274653 Dendritic cell immunoreceptors (dcir)-mediated crosspriming of human cd8+ t cells
11/10/2011	US20110274624 Contrast agents in porous particles
11/10/2011	US20110274623 Stabilized Fibronectin Domain Compositions, Methods and Uses
11/10/2011	CA2835313A1 Gfi1b modulation and uses thereof
11/09/2011	EP2385139A1 Polymorphisms for predicting disease and treatment outcome
11/09/2011	EP2385138A1 Polymorphisms for predicting disease and treatment outcome
11/09/2011	EP2385137A1 Polymorphisms for predicting disease and treatment outcome
11/09/2011	EP2385124A2 Peptides or peptide analogues for modulating the binding of a PDZ protein and a PL protein
11/09/2011	EP2385064A2 Agents disrupting a growth factor complex
11/09/2011	EP2385063A2 Growth factor complex
11/09/2011	EP2385040A1 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
11/09/2011	EP2385039A1 2-Iminoisoindolinone derivatives as thrombin receptor antagonists
11/09/2011	EP2385032A1 GPR40 Receptor function regulator
11/09/2011	EP2384751A1 Medicaments for the treatment or prevention of fibrotic diseases
11/09/2011	EP2384196A2 Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof
11/09/2011	EP2384112A1 A composition comprising nor-adrenaline and a net inhibitor for administering to a brain-dead, heart-beating potential organ donor.
11/09/2011	EP1813623B1 Purinenucleoside derivative modified in 8-position and medicinal use thereof
11/09/2011	EP1526862B1 Simmondsin for use as an angiogenesis inhibitor
11/09/2011	EP1343508B1 Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis
11/09/2011	EP1328624B1 B7-like molecules and uses thereof
11/09/2011	CN102239164A 2h-chromene compound and derivative thereof
11/09/2011	CN102239159A 7-piperidinoalkyl-3,4-dihydroquinolone derivative
11/09/2011	CN102239136A Casr agonist
11/09/2011	CN102238951A Pharmaceutical agent comprising quinolone compound
11/09/2011	CN102233077A Use of medicinal composition in preparation of medicine for improving activity of adenosine 5'-monophosphate-activated protein kinase (AMPK)
11/09/2011	CN102232996A Chinese medicine paste for treating lymphadenectasis
11/09/2011	CN102232975A Nontoxic medicine
11/09/2011	CN101857584B Hydroxyl flavanoid compound and application thereof
11/09/2011	CN101392026B Polypeptide for preventing and treating fibrotic disease and liver cancer
11/09/2011	CN101343251B Thrombopoietin mimetics
11/09/2011	CN101204537B Chinese traditional medicine composite for reducing spitting, dispelling wind, and relieving convulsion and preparation method thereof

1 ... 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 ... 1564